IGBZX Performance — Voya Global Bond Fund, Class R6
Data updated: 2026-09-25
IGBZX returned −1.77% year to date and +0.56% over one year to Jul 2026. Annualised returns are +3.32% over 3 years and −1.90% over 5 years. The fund trailed its Global Intermediate Core Bond category average: $100 invested three years ago grew to $110, against $115 for the category, and to $101 over one year, against $103. Volatility over the past three years was 7.41% a year. In the 12 months to Jul 2026 the fund lost a net $52.2M, and assets reached $78.84M.
IGBZX Growth of $100
What $100 invested in Voya Global Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Intermediate Core Bond category average over the same months.
| Period | IGBZX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $101 | $103 |
| 3 years (Aug 2023 – Jul 2026) | $110 | $115 |
| 5 years (Aug 2021 – Jul 2026) | $91 | $102 |
| Since data start (Aug 2019 – Jul 2026) | $93 | $111 |
IGBZX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −1.77% |
| 1 year | +0.56% |
| 3 years (annualised) | +3.32% |
| 5 years (annualised) | −1.90% |
IGBZX Annual Returns
Calendar-year total returns of Voya Global Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −1.77% |
| 2025 | +8.89% |
| 2024 | −0.81% |
| 2023 | +6.87% |
| 2022 | −17.51% |
| 2021 | −4.95% |
| 2020 | +4.73% |
| 2019 (Aug–Dec) | +0.01% |
IGBZX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.4% | +1.7% | −3.9% | +1.4% | +0.1% | −0.6% | −0.7% | — | — | — | — | — |
| 2025 | +0.7% | +1.8% | +0.4% | +2.9% | −0.2% | +2.5% | −1.9% | +1.8% | +0.5% | −0.4% | +0.4% | +0.1% |
| 2024 | −1.2% | −1.0% | +0.8% | −2.7% | +1.7% | +0.2% | +3.1% | +2.4% | +1.8% | −3.5% | +0.5% | −2.5% |
| 2023 | +3.7% | −3.3% | +2.8% | +0.6% | −2.0% | +0.2% | +0.9% | −1.3% | −3.3% | −1.4% | +5.7% | +4.4% |
| 2022 | −2.1% | −2.2% | −2.8% | −5.8% | +0.1% | −4.1% | +2.2% | −3.1% | −5.3% | −0.6% | +5.1% | −0.1% |
| 2021 | −0.7% | −1.6% | −2.0% | +1.3% | +0.9% | −1.0% | +0.9% | −0.3% | −1.6% | −0.4% | −0.6% | 0.0% |
| 2020 | 0.0% | 0.0% | −0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +2.6% | +2.0% |
| 2019 | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
IGBZX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 7.41%
- 3-year Sharpe ratio: -0.16 (vs 4.5% risk-free rate)
- Best month: +5.67% (Nov 2023)
- Worst month: −3.93% (Mar 2026)
IGBZX Fund Flows
Monthly money in and out of Voya Global Bond Fund, from SEC Form N-PORT.
- 12-month net flow: −$52.2M
- 12-month gross sales (incl. reinvestments): $28.9M
- Sales ÷ redemptions: 0.36×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $2.6M | $1.7M | $889K |
| Jun 2026 | $1.6M | $1.5M | $87K |
| May 2026 | $1.6M | $2.4M | −$740K |
| Apr 2026 | $1.9M | $1.8M | $154K |
| Mar 2026 | $1.3M | $2.0M | −$673K |
| Feb 2026 | $999K | $1.6M | −$553K |
| Jan 2026 | $2.2M | $55.0M | −$52.8M |
| Dec 2025 | $3.5M | $1.9M | $1.6M |
| Nov 2025 | $1.8M | $2.2M | −$411K |
| Oct 2025 | $6.5M | $2.3M | $4.1M |
| Sep 2025 | $2.5M | $7.1M | −$4.6M |
| Aug 2025 | $2.4M | $1.7M | $657K |
IGBZX Assets Under Management
Net assets of Voya Global Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $78.84M |
| 2026-04-30 | $80.44M |
| 2026-01-31 | $83.25M |
| 2025-10-31 | $135.24M |
| 2025-07-31 | $134.17M |
| 2025-04-30 | $133.17M |
| 2025-01-31 | $184.02M |
| 2024-10-31 | $186.57M |
| 2024-07-31 | $251.87M |
| 2024-04-30 | $254.39M |
| 2024-01-31 | $258.29M |
| 2023-10-31 | $281.13M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.